Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Texas Southwestern Medical Center
The purpose of this study is to test whether the structural and functional connectivity between the dorso-lateral prefrontal cortex (DLPFC) and amygdala will decline as symptoms of co-morbid anxiety (Anxiety Factor Score) increase in patients with MDD. This decrease in connectivity will also account for decrease in treatment response. The structural connectivity will be assessed using Diffusion Tensor Imaging (DTI) and the functional connectivity will be assessed using resting state BOLD fMRI.We propose to use the fMRI and DTI to identify biological markers that are associated with treatment response in a cohort of patients with a spectrum of Anxiety Factor Scores.
Age
18–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Competent to give informed consent
Diagnosis of Major Depressive Disorder
Males and females
Ages 18-50 years old
All races and ethnicities
Able to read, speak, and understand English\*
You may not be if
History of psychiatric illness except Major Depressive Disorder, Generalized Anxiety Disorder, Social Phobia, or Specific Phobia
Alcohol or substance abuse within the last 6 months or alcohol or substance dependence within the last year
Diagnosis of an organic brain disease
Serious unstable medical illness
History of serious head injury
Unsafe or unable to have an MRI or previous inability to tolerate MRI
Pregnancy or breast feeding
Clareo Health | Using Neuroimaging to Investigate Major Depressive Disorder
